Vitreous form of known bradykinin antagonist

Details Vitreous form of known bradykinin antagonist Vitreous form of known bradykinin antagonist

2006-08-22

2006-08-22

Seaman, D. Margaret (Department: 1625)

Organic compounds -- part of the class 532-570 series

Organic compounds

Heterocyclic carbon compounds containing a hetero ring...

C514S314000

Reexamination Certificate

active

07094899

ABSTRACT:
This invention relates to a vitreous form of 8-[3-[N-[(E)-3-(6-acetamidopyridin-3-yl)acryloylglycyl]-N-methylamino]-2,6-dichlorobenzyloxy]-2-methylquinoline (FR173657). This vitreous form has good solid stability and, therefor, is useful for producing and supplying FR173657 products whose quality is stable enough to be suitable for medicines.

REFERENCES:
patent: 5958455 (1999-09-01), Roser
patent: 0 622 361 (1994-02-01), None
patent: 0 662 361 (1994-11-01), None
patent: 10 316677 (1998-12-01), None

Affiliated with

Also associated with

Rating

Vitreous form of known bradykinin antagonist does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Vitreous form of known bradykinin antagonist, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Vitreous form of known bradykinin antagonist will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3654864